Tailoring Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Recent Advances and Strategies
JCO Oncol Pract
.
2024 Mar 12:OP2300563.
doi: 10.1200/OP.23.00563.
Online ahead of print.
Authors
Francisco J Esteva
1
2
,
Elena Katz
1
2
Affiliations
1
Northwell, New Hyde Park, NY.
2
Northwell Health Cancer Institute, Lake Success, NY.
PMID:
38471052
DOI:
10.1200/OP.23.00563
Abstract
Neoadjuvant HER2 Therapy: Beyond one-size-fits-all.
Publication types
Review